Dr. Cameron Clokie is known as an expert in the field of oral and maxillofacial surgeries. He is often looked to as a resource when individuals have questions, because he has served as a professor and a surgeon for many years.
What people might not know about Dr. Cameron Clokie is that he is also a serial entrepreneur. He is the CEO of a company by the name of “Induce Biologics Inc.”, which specializes in musculoskeletal reconstruction.
Dr. Cameron Clokie is went to dental school, and then continued with his education to pursue a PhD in bone regeneration. He graduated with this degree in 1992, and went on to perform breakthrough surgeries and conduct extensive research in the field of bone regeneration. This field was an interest point for him early on in his career, and guided his many research projects.
His clinical trials and research papers centered around new and unique ways to induce bone to regenerate. Because he was so focused and diligent with his research, he made progress and began to enter into new scientific territory.
Dr. Clokie shares his discoveries and through presentations all over the world, about new ways to perform bone reconstructive surgeries, and new techniques on the horizon for regenerative medicine. His business is based on his strong foundation in the field which his business relates to.
As a surgeon, he knows well the struggles that his patients experience when it comes to needing reconstructive surgeries. He has worked with many professionals and experts in the field, and his contacts gave him insight to many of the surrounding scientific fields.
He takes an innovative approach to oral and maxillofacial surgeries, which changed the options that patients have available. He pushed the boundaries of the procedures that were being done, and through research broke through to a new approach that would serve his clients in a better way than the existing model did.
Through his business, Cameron Clokie now has the opportunity to continue making new leaps and bounds within his specialty area which will take the field into new and uncharted areas. He holds 25 US and international patents which are either existing or pending approval.